{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:16:18Z","timestamp":1791324978991,"version":"4.3.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.dld.2019.11.010","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T01:02:37Z","timestamp":1575939757000},"page":"130-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Therapeutic options for coeliac disease: What else beyond gluten-free diet?"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4244-4529","authenticated-orcid":false,"given":"Giacomo","family":"Caio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-7576","authenticated-orcid":false,"given":"Rachele","family":"Ciccocioppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Zoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0867-5873","authenticated-orcid":false,"given":"Roberto","family":"De Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3405-3808","authenticated-orcid":false,"given":"Umberto","family":"Volta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2019.11.010_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12916-019-1380-z","article-title":"Celiac disease: a comprehensive current review","volume":"17","author":"Caio","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.dld.2019.11.010_bib0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Al-Toma","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2019.11.010_bib0015","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ajg.2014.29","article-title":"Patient perception of treatment burden is high in celiac disease compared with other common conditions","volume":"109","author":"Shah","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.11.010_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.fm.2006.07.004","article-title":"Chemistry of gluten proteins","volume":"24","author":"Wieser","year":"2007","journal-title":"Food Microbiol"},{"key":"10.1016\/j.dld.2019.11.010_bib0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1053\/j.gastro.2016.12.006","article-title":"Nutritional wheat amylase-trypsin inhibitors promote intestinal inflammation via activation of myeloid cells","volume":"152","author":"Zevallos","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrgastro.2015.90","article-title":"Novel players in coeliac disease pathogenesis: role of the gut microbiota","volume":"12","author":"Verdu","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.11.010_bib0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gutjnl-2014-306931","article-title":"The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease","volume":"64","author":"Olivares","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.11.010_bib0045","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa1404172","article-title":"Randomized feeding intervention in infants at high risk for celiac disease","volume":"371","author":"Vriezinga","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.11.010_bib0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bpg.2015.05.001","article-title":"Innate immunity: actuating the gears of celiac disease pathogenesis","volume":"29","author":"Kim","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2019.11.010_bib0055","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gutjnl-2011-300327","article-title":"Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis","volume":"61","author":"Heyman","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.11.010_bib0060","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(00)02169-3","article-title":"Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease","volume":"355","author":"Fasano","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2019.11.010_bib0065","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1053\/gast.2002.36578","article-title":"Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure","volume":"123","author":"El Asmar","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/gut.52.2.218","article-title":"Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function","volume":"52","author":"Clemente","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.11.010_bib0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2008.03.023","article-title":"Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3","volume":"135","author":"Lammers","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2007.136366","article-title":"Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue","volume":"57","author":"Schumann","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.11.010_bib0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20071204","article-title":"Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease","volume":"205","author":"Matysiak-Budnik","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.dld.2019.11.010_bib0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0889-8553(21)00570-7","article-title":"Intestinal intraepithelial lymphocytes","volume":"20","author":"Cerf-Bensussan","year":"1991","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.dld.2019.11.010_bib0095","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1309\/UV54-BHP3-A66B-0QUD","article-title":"Increased enterocyte apoptosis and Fas-Fas ligand system in celiac disease","volume":"15","author":"Ciccocioppo","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.dld.2019.11.010_bib0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","article-title":"Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease","volume":"55","author":"Di Sabatino","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.11.010_bib0105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature09849","article-title":"Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens","volume":"471","author":"DePaolo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.dld.2019.11.010_bib0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2249.2000.01200.x","article-title":"Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD)","volume":"120","author":"Ciccocioppo","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000369521","article-title":"Interleukin-15, a masterpiece in the immunological jigsaw of celiac disease","volume":"33","author":"Meresse","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.dld.2019.11.010_bib0120","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.dld.2019.11.010_bib0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fimmu.2019.00031","article-title":"p31-43 gliadin peptide forms oligomers and induces NLRP3 inflammasome\/caspase 1-dependent mucosal damage in small intestine","volume":"10","author":"G\u00f3mez Castro","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0130","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2013.12.023","article-title":"Interleukin 15 and CD4+ T Cells cooperate to promote small intestinal enteropathy in response to dietary antigen","volume":"146","author":"Korneychuk","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0135","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1053\/j.gastro.2007.08.018","article-title":"Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease","volume":"133","author":"Di Sabatino","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10875-008-9228-x","article-title":"In vitro differentiation of human monocytes into dendritic cells by peptic-tryptic digest of gliadin is independent of genetic predisposition and the presence of celiac disease","volume":"29","author":"Rakhimova","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0145","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mi.2010.36","article-title":"HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22","volume":"3","author":"Bodd","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0150","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1096\/fasebj.5.15.1683845","article-title":"Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues","volume":"5","author":"Greenberg","year":"1991","journal-title":"FASEB J"},{"key":"10.1016\/j.dld.2019.11.010_bib0155","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1572-0241.2003.07582.x","article-title":"Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease","volume":"98","author":"Esposito","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.11.010_bib0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.immunol.18.1.53","article-title":"Molecular basis of celiac disease","volume":"18","author":"Sollid","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2007.01471.x","article-title":"Genetic background of celiac disease and its clinical implications","volume":"103","author":"Wolters","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.11.010_bib0170","first-page":"S8","article-title":"Recent insight in the pathophysiology of coeliac disease: relevance to rheumatoid arthritis","volume":"33","author":"Koning","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.dld.2019.11.010_bib0175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-2249.1999.01054.x","article-title":"Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression","volume":"118","author":"Brusco","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0180","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ajg.2011.80","article-title":"IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in celiac disease","volume":"106","author":"Zanzi","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.11.010_bib0185","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ajg.2011.397","article-title":"Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?","volume":"107","author":"Hmida","year":"2012","journal-title":"Am J Gatroenterol"},{"key":"10.1016\/j.dld.2019.11.010_bib0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/labinvest.3700225","article-title":"Matrix metalloproteinase pattern in celiac duodenal mucosa","volume":"85","author":"Ciccocioppo","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.dld.2019.11.010_bib0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1542-3565(05)00366-6","article-title":"Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue","volume":"3","author":"Pyle","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.11.010_bib0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clim.2009.11.001","article-title":"The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo","volume":"134","author":"Tye-Din","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0205","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"L\u00e4hdeaho","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0210","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"L\u00e4hdeaho","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0220","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1007\/s10620-017-4687-7","article-title":"Latiglutenase improves symptoms in seropositive celiac disease patients while on a gluten-free diet","volume":"62","author":"Syage","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2019.11.010_bib0225","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3748\/wjg.v19.i35.5837","article-title":"Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study","volume":"19","author":"Tack","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.11.010_bib0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/apt.13266","article-title":"Randomised clinical study: aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers","volume":"42","author":"Salden","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.11.010_bib0235","doi-asserted-by":"crossref","first-page":"13100","DOI":"10.1038\/s41598-017-13587-7","article-title":"Randomized clinical trial: effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting","volume":"7","author":"K\u00f6nig","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2019.11.010_bib0240","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/jacs.5b08325","article-title":"Engineering of kuma030: a gliadin peptidase that rapidly degrades immunogenic gliadin peptides in gastric conditions","volume":"137","author":"Wolf","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.dld.2019.11.010_bib0245","doi-asserted-by":"crossref","first-page":"e6313","DOI":"10.1371\/journal.pone.0006313","article-title":"A Food-grade enzyme preparation with modest gluten detoxification properties","volume":"4","author":"Ehren","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.11.010_bib0250","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1251384","article-title":"Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases","volume":"4","author":"Sturgeon","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.dld.2019.11.010_bib0255","doi-asserted-by":"crossref","first-page":"16799","DOI":"10.1073\/pnas.0906773106","article-title":"Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2","volume":"106","author":"Tripathi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.dld.2019.11.010_bib0260","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/00365520500235334","article-title":"Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines","volume":"41","author":"Drago","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.11.010_bib0265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.peptides.2012.02.015","article-title":"Larazotide acetate regulates epithelial tight junctions in vitro and in vivo","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.dld.2019.11.010_bib0270","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.peptides.2012.02.016","article-title":"Larazotide acetate promotes tight junction assembly in epithelial cells","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.dld.2019.11.010_bib0275","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2007.03413.x","article-title":"The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study","volume":"26","author":"Paterson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.11.010_bib0280","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/ajg.2012.211","article-title":"A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge","volume":"107","author":"Leffler","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.11.010_bib0285","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.12147","article-title":"Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study","volume":"37","author":"Kelly","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.11.010_bib0290","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0295","first-page":"16","article-title":"Pathophysiology of non-celiac gluten sensitivity: where are we now?","volume":"63","author":"Caio","year":"2017","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.dld.2019.11.010_bib0300","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2741\/1843","article-title":"Tissue transglutaminase (TG2) - a wound response enzyme","volume":"11","author":"Telci","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/j.dld.2019.11.010_bib0305","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/ja056423o","article-title":"Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from \u03b12-gliadin","volume":"128","author":"Xia","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.dld.2019.11.010_bib0310","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10875-012-9745-5","article-title":"Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study","volume":"33","author":"Rauhavirta","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0315","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1073\/pnas.0832466100","article-title":"Transglutaminase 2-\/- mice reveal phagocytosis-associated crosstalk between macrophages and apoptotic cells","volume":"100","author":"Szondy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.dld.2019.11.010_bib0320","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.bmc.2007.10.091","article-title":"Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with celiac disease","volume":"16","author":"Kapoerchan","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.dld.2019.11.010_bib0325","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.molimm.2009.10.036","article-title":"Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule","volume":"47","author":"Kapoerchan","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0330","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/gast.2000.18149","article-title":"Interleukin 15 mediates epithelial changes in celiac disease","volume":"119","author":"Maiuri","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0335","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study","author":"L\u00e4hdeaho","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.11.010_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.11.010_bib0345","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10875-012-9849-y","article-title":"Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease","volume":"33","author":"Yokoyama","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0350","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.coi.2013.02.004","article-title":"Vaccine against autoimmune disease: antigen-specific immunotherapy","volume":"25","author":"Anderson","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.dld.2019.11.010_bib0355","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1016\/S0016-5085(11)61794-0","article-title":"A phase I study to determine safety, tolerability and bioactivity of Nexvax2\u00ae in HLA DQ2+ volunteers with celiac disease following a long-term, strict gluten-free diet","volume":"140","author":"Brown","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.11.010_bib0360","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.11.010_bib0365","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ebiom.2017.11.018","volume":"26","author":"Daveson","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.dld.2019.11.010_bib0370","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00018-014-1797-7","article-title":"Are stem cells a potential therapeutic tool in coeliac disease?","volume":"72","author":"Ciccocioppo","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.dld.2019.11.010_bib0375","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interaction between human mesenchymal stem cells and natural killer cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.dld.2019.11.010_bib0380","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.dld.2019.11.010_bib0385","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.2535","article-title":"Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity","volume":"218","author":"Yabana","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.dld.2019.11.010_bib0390","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/cdd.2009.187","article-title":"Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis","volume":"17","author":"S\u00e9emont","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.dld.2019.11.010_bib0395","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2007.10.002","article-title":"Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation","volume":"115","author":"English","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.dld.2019.11.010_bib0400","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcyt.2014.03.002","article-title":"Tolerogenic effect of mesenchymal stromal cells on gliadin-specific T lymphocytes in celiac disease","volume":"168","author":"Ciccocioppo","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.dld.2019.11.010_bib0405","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.mayocp.2016.03.001","article-title":"A refractory celiac patient successfully treated with mesenchymal stem cell infusions","volume":"91","author":"Ciccocioppo","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.dld.2019.11.010_bib0410","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMra020100","article-title":"The effect of infections on susceptibility to autoimmune and allergic diseases","volume":"347","author":"Bach","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.11.010_bib0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017366","article-title":"Effect of hookworm infection on wheat challenge in celiac disease \u2014 a randomised double-blinded placebo-controlled trial","volume":"6","author":"Daveson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.11.010_bib0420","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2014.07.022","article-title":"Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease","volume":"135","author":"Croese","year":"2015","journal-title":"J Allergy Clin Immunol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819309193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819309193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:11:49Z","timestamp":1761624709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865819309193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1590865819309193"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2019.11.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic options for coeliac disease: What else beyond gluten-free diet?","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2019.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}